Kerry Holford's Stock Ratings

Berenberg Analyst

Kerry Holford is an analyst at Berenberg. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

10.8%

Smart Score

48.7%

Overall Average Return Percentile

59th

Number of Ratings

10
Buy NowGet Alert
09/17/2025NVOBuy Now
Novo Nordisk
$49.69UpgradeHold → BuyGet Alert
09/17/2025LLYBuy Now
Eli Lilly
$1.07K-22.34%$970 → $830DowngradeBuy → HoldGet Alert
08/14/2024LLYBuy Now
Eli Lilly
$1.07K-1.76%$1000 → $1050MaintainsBuyGet Alert
07/11/2024LLYBuy Now
Eli Lilly and Co
$1.07K-6.44%$850 → $1000MaintainsBuyGet Alert
11/22/2022LLYBuy Now
Eli Lilly
$1.07K-64.91%$345 → $375MaintainsBuyGet Alert
12/20/2021LLYBuy Now
Eli Lilly
$1.07K-71.46%$270 → $305MaintainsBuyGet Alert
10/11/2021LLYBuy Now
Eli Lilly
$1.07K-74.74%$240 → $270UpgradeHold → BuyGet Alert
09/29/2020LLYBuy Now
Eli Lilly
$1.07K-86.53% → $144Initiates → HoldGet Alert
07/25/2018LLYBuy Now
Eli Lilly
$1.07KDowngradeBuy → HoldGet Alert
08/27/2015LLYBuy Now
Eli Lilly
$1.07K-90.64% → $100Initiates → BuyGet Alert